<http://webisa.webdatacommons.org/204597396>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/204597396>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<bio-medicine.org> .
<http://webisa.webdatacommons.org/prov/239581770>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/204597396> .
<http://webisa.webdatacommons.org/204597396>	<http://www.w3.org/ns/prov#value>	"This trial is a Phase II, open-label, single agent study whose primary" .